Final version! Information on 196 third batch of volume procurement bidding enterprises.

Text . . . Fengqiu July 29, 2020, the State Organization of drug centralized procurement and use of the Joint Procurement Office issued the "National Drug Centralized Procurement Document", the country's 56 varieties of drugs collection officially opened.
the notice, the relevant pharmaceutical companies on August 20 at 7:30 a.m. to start filing documents.
tomorrow's enterprise winning rules are as follows: (1) Declaration of eligibility: follow the old rules.
the original research or evaluation of preparations, through consistent evaluation, according to the new registration of chemicals approved generic drugs, included in the Listed Drugs Catalog of drugs.
(2) declared price ceiling: "Unit declared price" should be less than or equal to the corresponding specifications of the purchased variety "maximum effective declared price."
This collection document was issued, along with the variety and procurement volume, published each variety and specification corresponding to the "maximum effective declared price" (3) procurement volume determination and procurement cycle: the number of selected enterprises directly linked to the procurement volume and procurement cycle, but the agreement is still signed every year.
(4) Selected enterprises: the rules adopt a more rigorous and reasonable approach, similar to the second batch of national collection rules, but because some varieties of competition more enterprises, set up a wider number of finalists, to a certain extent to avoid the situation of low price competition re-emerged.
even if only three shortlisted companies are no longer "rest easy", the same price war.
In addition, the second batch of national collection of three shortlisted enterprises to be selected for the qualification "through card" rule is still retained, that is: the finalist enterprise price meets one of the following conditions, to obtain the proposed selection qualification: 1) "unit comparable price" the lowest "unit comparable price" of the same variety 1.8 times.
2) "Unit declaration price" decrease of 50.00% (based on the maximum effective declared price corresponding to the specifications of the Purchase Variety Catalog).
decrease is measured as a percentage, rounding the retention percentage after 2 places after the point of the few points.
3) "Units can be compared price" of 0.1000 yuan.
(5) Supply confirmation: the proposed enterprise unified access to the supply area confirmation procedures.
the lowest-priced enterprises still enjoy certain advantages, can be preferred 1 region.
the priority selection is completed, the proposed enterprise shall alternately confirm the supply area according to the declared price from low to high, and each round must be confirmed, and no waiver shall be made, otherwise the proposed winning bid shall be disqualified.
is extremely important for certain varieties, and from past experience, some companies are willing to make a profit in order to prioritize the desired area, resulting in lower offers.
According to the variety, apixaban tablets, metformin hydrochloride slow-release tablets, oral regular release preparations for metformin hydrochloric acid, non-amine tablets, katopri tablets, Monrust sodium chew tablets, tigry Lo tablets,acid tofatin cloth tablets, Viglitin tablets, hydrochloric acid citric acid tablets, salatin oral regular release agent several varieties, competitors are in 7 and above, that is to say, there will be more cases of selected manufacturers.
dy metformin slow release dosage form and metformin oral regular release dosage form 2 varieties are facing dozens of enterprises to compete for a large number of elimination scenes, and some cancer drugs and chronic disease drugs have become the focus of this collection, there is the first appearance of eye drops varieties are also worth noting.
From the point of view of enterprises: generic drug "big household" Yangzijiang, there are as many as 12 varieties are expected to participate in the competition, namely, finasteride tablets, omeprazole intestinal capsules, Monrust sodium chewing tablets, left oxyfluorosa star drops Eye fluid, ibuprofen particles, tigrillo tablets, viglitin tablets, hydrochloric acid melanin tablets, hydrochloric acid citric acid tablets,acid tofatin tablets, anaquic tablets, methylcobalamin tablets.
stone drug Ouyi also has 9 varieties to participate in the competition, namely, Monrust sodium chewing tablets, ibuprofen particles, hydrochloric acid metformin slow release tablets, katopril tablets, hydrochloric acid metformin tablets, hydrochloric acid methicillin tablets, tegrilo tablets, celexib capsules, kramycin tablets.
in the 4 plus 7 expansion period to invest in the most active Qilu pharmaceutical, this time is still the focus of enterprises, there are 8 varieties may enter the killing, respectively: relying on the kaoxi tablets, Monrust sodium chewing tablets, caperta bin tablets, o nitrogen flat mouth collapse tablets, Viglitin tablets,acid tofatin tablets, apixaban tablets,acid sidina non-slices.
, Hengrui Pharmaceuticals and Colum Pharmaceuticals are also eligible to compete in six different varieties.
the following is the list of competitors eligible to participate in this batch of 56 varieties, some enterprises have a number of varieties to participate in bidding, a total of 196 enterprises, for reference only.
old rules, I wish you all good luck tomorrow! The third batch of national procurement varieties of campaign manufacturers (as of 2020/8/19)